Continuous Blood Glucose Monitoring Systems Market

Request Discount

Continuous Blood Glucose Monitoring Systems Market (Component - CGM Monitor, CGM Transmitter, and Glucose Sensor): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : May, 2019

  • Rep Id : HC0490

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on continuous blood glucose monitoring systems market provides depth analysis of segments and sub-segments in the global as well as regional continuous blood glucose monitoring systems market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional continuous blood glucose monitoring systems market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global continuous blood glucose monitoring systems market. According to the report, the global continuous blood glucose monitoring systems market is projected to grow at a CAGR of 23.1% over the forecast period of 2019-2025.

Global Continuous Blood Glucose Monitoring Systems Market


Market Insight

During the last four decades, there have been continuous advances in the field of glucose monitoring, which have led to the development of highly evolved blood glucose meters, including non-invasive glucose monitoring (NGM) devices and continuous blood glucose monitoring systems (CGM). Glucose monitoring is an integral part of diabetes management and the maintenance of physiological blood glucose concentration is the only way for a diabetic to avoid life-threatening diabetic complications. CGM systems have led to tremendous improvements in diabetic management, as shown by the significant lowering of glycated hemoglobin (HbA1c) in adults with type I diabetes. Most of the CGMS has been minimally-invasive, although the more recent ones are based on NGM techniques


Diabetes disease is growing across the globe at an extraordinary pace and has become a serious health issue during the last two decades. It is a major cause of mortality in the age group of 20–79 years. Based on its rapidly increasing incidence, it has been declared a global epidemic by the World Health Organization (WHO). According to the International Diabetes Federation (IDF), the number of diabetic patients reached 415 million in 2015 globally and is expected to reach around 642 million by 2040. According to the IDF, global healthcare expenditures to treat diabetes and its complications were USD 673 billion in 2015, representing 12% of total global healthcare expenditures and is expected to exceed USD 802 billion by 2040. Rise in the base of geriatric population, increasing incidence rates of diabetes worldwide, benefits of CBGM devices over blood glucometers such as reports generation and access for historic blood glucose data to analyze the trend, growing awareness among the population, increasing preference for non-invasive methods and approval of artificial pancreas from FDI is expected to drive the market at a significant growth rate in the coming years. However, stringent regulatory approvals and high costs associated with these devices are some of the restraining factors, which could hinder the market.


Among the geographies, North America holds the maximum market share of continuous blood glucose monitoring systems (CGM) market followed by Europe. The rapidly growing prevalence of diabetes and growing awareness about the prevention of diabetes is the key factors that drive the growth of North America continuous glucose monitoring system market. Additionally, favorable government and developed healthcare infrastructures are majorly contributing to the growth of this market in the North America region. Moreover, Asia Pacific is the fastest growing region in the glucose monitoring systems (CGM) market owing to the growing prevalence of diabetes, rapidly changing lifestyles, and growing geriatric population.


Segment Covered

The report on global continuous blood glucose monitoring systems market covers segments such as component. On the basis of component, the sub-markets include CGM monitor, CGM transmitter, and glucose sensor.


Companies Profiled:

The report provides profiles of the companies in the market such as Dexcom, Inc., Medtronic plcAbbott LaboratoriesIntegrity Applications IncorporatedNovo Nordisk A/SORSENSE LTD, Bayer AG, Johnson & Johnson Services, Inc.Senseonics Holdings, Inc., and Other Companies.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of continuous blood glucose monitoring systems market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount